Nrx pharmaceuticals publishes shareholder update letter

Focus on implications of the recent data sharing agreement relating to a landmark trial of ketamine in the treatment of suicidal depression nmda antagonist highly effective in bipolar subgroup (p

NRXP Ratings Summary

NRXP Quant Ranking